127 results on '"Lacombe, Denis"'
Search Results
2. Inclusion of functional measures and frailty in the development and evaluation of medicines for older adults
3. Current models, challenges and best practices for work conducted between European academic cooperative groups and industry
4. Safeguarding the future of independent, academic clinical cancer research in Europe for the benefit of patients
5. The European Cancer Patient’s Bill of Rights, update and implementation 2016
6. How do cancer clinicians perceive real-world data and the evidence derived therefrom? Findings from an international survey of the European Organisation for Research and Treatment of Cancer
7. Collaboration between EORTC and JCOG—how to accelerate global clinical research partnership
8. Major achievements of the EORTC Cutaneous Lymphoma Task Force (CLTF)
9. EORTC topics in neurooncology: The long path from a focus on neurological complications of cancer towards molecularly defined trials and therapies in neurooncology
10. 50 years of the EORTC and the central role of the EORTC Headquarters
11. Towards a Cancer Mission in Horizon Europe
12. The Porto European Cancer Research Summit 2021
13. The dream and reality of histology agnostic cancer clinical trials
14. Towards personalized medicine in the EU: what is needed to facilitate the complex international clinical research?
15. Current models, challenges and best practices for work conducted between European academic cooperative groups and industry
16. Cross-Border Access to Clinical Trials in the EU: Exploratory Study on Needs and Reality
17. Past, Current, and Future Cancer Clinical Research Collaborations: The Case of the European Organisation for Research and Treatment of Cancer
18. Towards a cancer mission in Horizon Europe: recommendations
19. Sharing of Clinical Trial Data and Samples: The Cancer Patient Perspective
20. Views of European Drug Development Stakeholders on Treatment Optimization and Its Potential for Use in Decision-Making
21. Moving forward from drug-centred to patient-centred research
22. Project management platform in an academic environment: the EORTC's promising experience: a new, standard-based approach minimizes the delays between discovery of innovative agents and identification of their therapeutic benefit for patients--critical in cancer research
23. EORTC's Regulatory Affairs Unit: facilitating European cancer research: improving cancer treatment is the mission of the EORTC's Regulatory Affairs Unit. (Focus On Europe)
24. Moving forward from drug-centred to patient-centred research
25. Late translational research: putting forward a new model for developing new anti‐cancer treatments that addresses the needs of patients and society
26. Responding to the challenges of international collaborations between the east and the west – report of the first JCOG–EORTC symposium and a perspective from young JCOG and EORTC investigators
27. Past, Current, and Future Cancer Clinical Research Collaborations: The Case of the European Organisation for Research and Treatment of Cancer.
28. Integration of Translational Research in the European Organization for Research and Treatment of Cancer Research (EORTC) Clinical Trial Cooperative Group Mechanisms
29. Toward a Tiered Model to Share Clinical Trial Data and Samples in Precision Oncology
30. From bench to clinical trials the EORTC experience in biology-based clinical cancer research
31. Precision Medicine: From “Omics” to Economics towards Data-Driven Healthcare - Time for European Transformation
32. Making Change Happen in Health
33. PASSIVE COMPONENT EMBEDDING IN PRINTED CIRCUIT BOARDS FOR SPACE APPLICATIONS
34. Collaboration between EORTC and JCOG—how to accelerate global clinical research partnership
35. Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers Initiative
36. Responding to the challenges of international collaborations between the east and the west – report of the first JCOG–EORTC symposium and a perspective from young JCOG and EORTC investigators.
37. The changing world of drug development: an academic research organization's perspective on the 'Seven Wonders' of the future world of anticancer drug development
38. Study risk assessment of JCOG clinical trials using the EORTC study risk calculator
39. International Rare Cancers Initiative (IRCI)
40. Integration of Translational Research in the European Organization for Research and Treatment of Cancer Research (EORTC) Clinical Trial Cooperative Group Mechanisms
41. Abstract C220: Combining novel targeted therapies and radiotherapy: A challenge to overcome.
42. International clinical trials setting for rare cancers: organisational and regulatory constraints—the EORTC perspective
43. Integrating Collection of Biospecimens in Clinical Trials: The Approach of the European Organization for Research and Treatment of Cancer
44. International investigator-driven clinical trials: challenges and opportunities for US–Europe cooperation through the US cooperative group networks
45. The EORTC Cutaneous T-Cell Lymphoma (CTCL) Platform
46. IDH1 and IDH2 Mutations Are Prognostic but not Predictive for Outcome in Anaplastic Oligodendroglial Tumors: A Report of the European Organization for Research and Treatment of Cancer Brain Tumor Group
47. Phase I Clinical and Magnetic Resonance Imaging Study of the Vascular Agent NGR-hTNF in Patients with Advanced Cancers (European Organization for Research and Treatment of Cancer Study 16041)
48. Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951
49. Phase I Combining a P-Glycoprotein Inhibitor, MS209, in Combination with Docetaxel in Patients with Advanced Malignancies
50. New validated prognostic models and prognostic calculators in patients with low-grade gliomas diagnosed by central pathology review: a pooled analysis of EORTC/RTOG/NCCTG phase III clinical trials.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.